SLC4A1 and systemic lupus erythematosus: The analysis of DEGs, including the downregulation of SLC4A1 and EPB42 and the upregulation of PIP4K2A, highlighted potential molecular mechanisms contributing to SLE pathogenesis, particularly in antiviral pathways.